BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29540858)

  • 1. miR-9-5p, miR-124-3p, and miR-132-3p regulate BCL2L11 in tuberous sclerosis complex angiomyolipoma.
    Cai Y; Wang W; Guo H; Li H; Xiao Y; Zhang Y
    Lab Invest; 2018 Jul; 98(7):856-870. PubMed ID: 29540858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MicroRNA differential expression profile in tuberous sclerosis complex cell line TSC2
    Cai Y; Guo H; Li HZ; Wang WD; Zhang YS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):580-584. PubMed ID: 28816269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A distinct microRNA expression profile is associated with α[
    Bagla S; Cukovic D; Asano E; Sood S; Luat A; Chugani HT; Chugani DC; Dombkowski AA
    Neurobiol Dis; 2018 Jan; 109(Pt A):76-87. PubMed ID: 28993242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal serum microRNA profiles in tuberous sclerosis are normalized during treatment with everolimus: possible clinical implications.
    Trelinska J; Fendler W; Dachowska I; Kotulska K; Jozwiak S; Antosik K; Gnys P; Borowiec M; Mlynarski W
    Orphanet J Rare Dis; 2016 Sep; 11(1):129. PubMed ID: 27680012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening of circRNAs reveals novel mechanisms of tuberous sclerosis complex-related renal angiomyolipoma.
    Zhao Y; Guo H; Wang W; Zheng G; Wang Z; Wang X; Zhang Y
    Hum Genomics; 2021 Jul; 15(1):43. PubMed ID: 34243823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas.
    Henske EP; Neumann HP; Scheithauer BW; Herbst EW; Short MP; Kwiatkowski DJ
    Genes Chromosomes Cancer; 1995 Aug; 13(4):295-8. PubMed ID: 7547639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human TSC-associated renal angiomyolipoma cells are hypersensitive to ER stress.
    Siroky BJ; Yin H; Babcock JT; Lu L; Hellmann AR; Dixon BP; Quilliam LA; Bissler JJ
    Am J Physiol Renal Physiol; 2012 Sep; 303(6):F831-44. PubMed ID: 22791333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients.
    Habib SL
    Mol Cancer; 2009 Mar; 8():13. PubMed ID: 19265534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells.
    Wang X; Zhao Y; Wang Z; Liao Z; Zhang Y
    Cell Biochem Biophys; 2022 Dec; 80(4):681-687. PubMed ID: 36181622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex.
    Yang HM; Choi HJ; Hong DP; Joo SY; Lee NE; Song JY; Choi YL; Lee J; Choi D; Kim B; Park HJ; Park JB; Kim SJ
    Exp Mol Pathol; 2014 Dec; 97(3):440-4. PubMed ID: 25281918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
    Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
    PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor.
    Pawlik B; Grabia S; Smyczyńska U; Fendler W; Dróżdż I; Liszewska E; Jaworski J; Kotulska K; Jóźwiak S; Młynarski W; Trelińska J
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis.
    Feng Y; Mischler WJ; Gurung AC; Kavanagh TR; Androsov G; Sadow PM; Herbert ZT; Priolo C
    Cancer Res; 2020 Jul; 80(13):2751-2763. PubMed ID: 32393662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
    Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
    J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
    Lam HC; Siroky BJ; Henske EP
    Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile.
    Pawlik B; Smyczyńska U; Grabia S; Fendler W; Dróżdż I; Bąbol-Pokora K; Kotulska K; Jóźwiak S; Borkowska J; Młynarski W; Trelińska J
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coding and small non-coding transcriptional landscape of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment.
    Mills JD; Iyer AM; van Scheppingen J; Bongaarts A; Anink JJ; Janssen B; Zimmer TS; Spliet WG; van Rijen PC; Jansen FE; Feucht M; Hainfellner JA; Krsek P; Zamecnik J; Kotulska K; Jozwiak S; Jansen A; Lagae L; Curatolo P; Kwiatkowski DJ; Pasterkamp RJ; Senthilkumar K; von Oerthel L; Hoekman MF; Gorter JA; Crino PB; Mühlebner A; Scicluna BP; Aronica E
    Sci Rep; 2017 Aug; 7(1):8089. PubMed ID: 28808237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.
    Calsina B; Castro-Vega LJ; Torres-Pérez R; Inglada-Pérez L; Currás-Freixes M; Roldán-Romero JM; Mancikova V; Letón R; Remacha L; Santos M; Burnichon N; Lussey-Lepoutre C; Rapizzi E; Graña O; Álvarez-Escolá C; de Cubas AA; Lanillos J; Cordero-Barreal A; Martínez-Montes ÁM; Bellucci A; Amar L; Fernandes-Rosa FL; Calatayud M; Aller J; Lamas C; Sastre-Marcos J; Canu L; Korpershoek E; Timmers HJ; Lenders JW; Beuschlein F; Fassnacht-Capeller M; Eisenhofer G; Mannelli M; Al-Shahrour F; Favier J; Rodríguez-Antona C; Cascón A; Montero-Conde C; Gimenez-Roqueplo AP; Robledo M
    Theranostics; 2019; 9(17):4946-4958. PubMed ID: 31410193
    [No Abstract]   [Full Text] [Related]  

  • 19. Genotype-phenotype correlation of patients with tuberous sclerosis complex-associated renal angiomyolipoma: a descriptive study.
    Li S; Zhang Y; Wang Z; Yang Y; Gao W; Li D; Wei J
    Hum Pathol; 2018 Dec; 82():61-67. PubMed ID: 30036593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-222 alleviates radiation-induced apoptosis by targeting BCL2L11 in cochlea hair cells.
    Zhang YY; Xiong GY; Xie XX
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33942856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.